To identify distinct molecular signatures and to assess potential molecular heterogeneity within ALK+ALCL, we performed an unsupervised clustering analysis of RNAseq data from 32 diagnostic samples, excluding the four relapsed samples (Supplementary Table S1 and Figure S1). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.